Acceleron Pharma Inc. Information Request Form
Levi & Korsinsky announces it has commenced an investigation of Acceleron Pharma Inc. (NASDAQ: XLRN) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.